tiprankstipranks
Mabpharm Limited Reports Mixed Mid-Year Results
Company Announcements

Mabpharm Limited Reports Mixed Mid-Year Results

Mabpharm Limited (HK:2181) has released an update.

Don't Miss our Black Friday Offers:

Mabpharm Limited has reported a 146.4% surge in revenue for the first half of 2024, compared to the same period in 2023, despite a slight decrease in net losses and a drop in gross profit. However, the company’s net assets have seen a significant decline of 43.8%, reflecting potential challenges ahead. This performance update may attract investors’ attention due to the notable changes in financial figures.

For further insights into HK:2181 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App